297 related articles for article (PubMed ID: 22149339)
1. Allergy to monoclonal antibodies: cutting-edge desensitization methods for cutting-edge therapies.
Hong DI; Bankova L; Cahill KN; Kyin T; Castells MC
Expert Rev Clin Immunol; 2012 Jan; 8(1):43-52; quiz 53-4. PubMed ID: 22149339
[TBL] [Abstract][Full Text] [Related]
2. A new pediatric protocol for rapid desensitization to monoclonal antibodies.
Caimmi SM; Caimmi D; Riscassi S; Marseglia GL
Int Arch Allergy Immunol; 2014; 165(3):214-8. PubMed ID: 25531534
[TBL] [Abstract][Full Text] [Related]
3. Rapid desensitization for hypersensitivity reactions to chemotherapy agents.
Castells M
Curr Opin Allergy Clin Immunol; 2006 Aug; 6(4):271-7. PubMed ID: 16825867
[TBL] [Abstract][Full Text] [Related]
4. Rapid drug desensitization for hypersensitivity reactions to chemotherapy and monoclonal antibodies in the 21st century.
Castells Guitart MC
J Investig Allergol Clin Immunol; 2014; 24(2):72-9; quiz 2 p following 79. PubMed ID: 24834769
[TBL] [Abstract][Full Text] [Related]
5. Hypersensitivity reactions and anaphylaxis to checkpoint inhibitor-monoclonal antibodies and desensitization.
Labella M; Castells M
Ann Allergy Asthma Immunol; 2021 Jun; 126(6):623-629. PubMed ID: 33781937
[TBL] [Abstract][Full Text] [Related]
6. Indications, protocols, and outcomes of drug desensitizations for chemotherapy and monoclonal antibodies in adults and children.
Hong DI; Dioun AF
J Allergy Clin Immunol Pract; 2014; 2(1):13-9; quiz 20. PubMed ID: 24565764
[TBL] [Abstract][Full Text] [Related]
7. Management and preparedness for infusion and hypersensitivity reactions.
Lenz HJ
Oncologist; 2007 May; 12(5):601-9. PubMed ID: 17522249
[TBL] [Abstract][Full Text] [Related]
8. Management and successful desensitization in methotrexate-induced anaphylaxis.
Bouchireb K; Dodille A; Ponvert C; Gouraud F; Dubrel M; Brugières L
Pediatr Blood Cancer; 2009 Feb; 52(2):295-7. PubMed ID: 18855892
[TBL] [Abstract][Full Text] [Related]
9. Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.
Mezzano V; Giavina-Bianchi P; Picard M; Caiado J; Castells M
BioDrugs; 2014 Apr; 28(2):133-44. PubMed ID: 23990250
[TBL] [Abstract][Full Text] [Related]
10. Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment.
Brennan PJ; Rodriguez Bouza T; Hsu FI; Sloane DE; Castells MC
J Allergy Clin Immunol; 2009 Dec; 124(6):1259-66. PubMed ID: 19910036
[TBL] [Abstract][Full Text] [Related]
11. Desensitization for hypersensitivity reactions to medications.
del Carmen Sancho M; Breslow R; Sloane D; Castells M
Chem Immunol Allergy; 2012; 97():217-33. PubMed ID: 22613865
[TBL] [Abstract][Full Text] [Related]
12. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement.
Cernadas JR; Brockow K; Romano A; Aberer W; Torres MJ; Bircher A; Campi P; Sanz ML; Castells M; Demoly P; Pichler WJ;
Allergy; 2010 Nov; 65(11):1357-66. PubMed ID: 20716314
[TBL] [Abstract][Full Text] [Related]
13. Successful desensitization to natalizumab in a skin test--positive patient: a case report.
Bignardi D; Ribizzi G; Voltolini S; Serrati C; Troise C
Eur Ann Allergy Clin Immunol; 2012 Feb; 44(1):26-9. PubMed ID: 22519129
[TBL] [Abstract][Full Text] [Related]
14. Desensitization regimens for drug allergy: state of the art in the 21st century.
Liu A; Fanning L; Chong H; Fernandez J; Sloane D; Sancho-Serra M; Castells M
Clin Exp Allergy; 2011 Dec; 41(12):1679-89. PubMed ID: 21883538
[TBL] [Abstract][Full Text] [Related]
15. Immediate adverse reactions to biologicals: from pathogenic mechanisms to prophylactic management.
Vultaggio A; Maggi E; Matucci A
Curr Opin Allergy Clin Immunol; 2011 Jun; 11(3):262-8. PubMed ID: 21460715
[TBL] [Abstract][Full Text] [Related]
16. Acute infusion reactions induced by monoclonal antibody therapy.
Maggi E; Vultaggio A; Matucci A
Expert Rev Clin Immunol; 2011 Jan; 7(1):55-63. PubMed ID: 21162650
[TBL] [Abstract][Full Text] [Related]
17. Managing premedications and the risk for reactions to infusional monoclonal antibody therapy.
Chung CH
Oncologist; 2008 Jun; 13(6):725-32. PubMed ID: 18586928
[TBL] [Abstract][Full Text] [Related]
18. Anaphylaxis and desensitization to the murine monoclonal antibody used for renal graft rejection.
Georgitis JW; Browning MC; Steiner D; Lorentz WB
Ann Allergy; 1991 Apr; 66(4):343-7. PubMed ID: 1901692
[TBL] [Abstract][Full Text] [Related]
19. Infusion reactions to monoclonal antibodies for solid tumors: immunologic mechanisms and risk factors.
Chung CH; O'Neil BH
Oncology (Williston Park); 2009 Feb; 23(2 Suppl 1):14-7. PubMed ID: 19385162
[TBL] [Abstract][Full Text] [Related]
20. Successful desensitization to imiglucerase of an adult patient diagnosed with type I Gaucher disease.
Erdoğdu D; Gelincik A; Canbaz B; Colakoğlu B; Büyüköztürk S; Tanakol R
Int Arch Allergy Immunol; 2013; 160(2):215-7. PubMed ID: 23018845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
